A new trading day began on Monday, with Moderna Inc (NASDAQ: MRNA) stock price up 1.64% from the previous day of trading, before settling in for the closing price of $65.75. MRNA’s price has ranged from $62.55 to $170.47 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 662.08% over the last five years. Meanwhile, its annual earnings per share averaged 22.44%. With a float of $342.77 million, this company’s outstanding shares have now reached $382.00 million.
The firm has a total of 5600 workers. Let’s measure their productivity.
Moderna Inc (MRNA) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Moderna Inc is 10.83%, while institutional ownership is 67.96%. The most recent insider transaction that took place on Sep 09 ’24, was worth 40,539. In this transaction Chief Legal Officer of this company sold 551 shares at a rate of $73.57, taking the stock ownership to the 18,154 shares. Before that another transaction happened on Sep 09 ’24, when Company’s Officer proposed sale 551 for $73.57, making the entire transaction worth $40,539.
Moderna Inc (MRNA) Recent Fiscal highlights
#####
According to the Wall Street analysts, stocks earnings will be around 22.44% per share during the next fiscal year.
Moderna Inc (NASDAQ: MRNA) Trading Performance Indicators
Here are Moderna Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.92. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.10.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -15.38, a number that is poised to hit -1.85 in the next quarter and is forecasted to reach -8.17 in one year’s time.
Technical Analysis of Moderna Inc (MRNA)
Analysing the last 5-days average volume posted by the [Moderna Inc, MRNA], we can find that recorded value of 4.74 million was better than the volume posted last year of 4.33 million. As of the previous 9 days, the stock’s Stochastic %D was 19.72%. Additionally, its Average True Range was 3.60.
During the past 100 days, Moderna Inc’s (MRNA) raw stochastic average was set at 3.23%, which indicates a significant decrease from 20.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 62.48% in the past 14 days, which was lower than the 67.33% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $84.03, while its 200-day Moving Average is $105.45. Now, the first resistance to watch is $68.09. This is followed by the second major resistance level at $69.35. The third major resistance level sits at $70.74. If the price goes on to break the first support level at $65.44, it is likely to go to the next support level at $64.05. Now, if the price goes above the second support level, the third support stands at $62.79.
Moderna Inc (NASDAQ: MRNA) Key Stats
With a market capitalization of 25.69 billion, the company has a total of 383,240K Shares Outstanding. Currently, annual sales are 6,848 M while annual income is -4,714 M. The company’s previous quarter sales were 241,000 K while its latest quarter income was -1,279 M.
